5-(6-bromohexyl)-3-methylisoxazole | 98033-83-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-(6-bromohexyl)-3-methylisoxazole
• 英文别名: 5-(6-bromohexyl)-3-methyl-1,2-oxazole
• CAS: 98033-83-1
• 化学式: C₁₀H₁₆BrNO
• 分子量: 246.147
• InChiKey: QTSLDCIOIQWTNO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  26
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-(6-bromohexyl)-3-methylisoxazole 生成 5-{6-[4-(4,5-Dihydro-2-oxazolyl)phenoxy]hexyl}-3-methylisoxazole
  参考文献：
  名称：

  Di-heterocyclic compounds and their use as antiviral agents

  摘要：

  公式化合物：##STR1## 其中Het是噁唑或噁唑啉基团；X是O、S或SO，n是从3到9的整数，Y是脂肪桥；各种R基团代表氢或如本文所述的各种取代基，可用作抗病毒剂，特别是对抗小RNA病毒。用于公式I化合物的N-(氯烷基)酰胺中间体也作为抗病毒剂活性。还披露了超出上述公式范围的相关化合物。

  公开号：

  US04843087A1
• 作为产物：
  描述：

  3,5-二甲基异唑 、 1,5-二溴戊烷 在 正丁基锂 、 二异丙胺 作用下， 生成 5-(6-bromohexyl)-3-methylisoxazole
  参考文献：
  名称：

  [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating

  摘要：

  A series of [[(4,5-dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles has been synthesized and evaluated as antipicornavirus agents. The effect of alkyl groups in the 4- and 5-position of the oxazoline ring, as well as the alkyl chain length, on antiviral activity was examined. Compound 14 was evaluated in vivo and was found to significantly reduce mortality at an oral dose of 4 mg/kg in mice infected intracerebrally with poliovirus-2. Compound 14 was also effective in preventing paralysis when administered intraperitoneally to mice infected subcutaneously with a lethal dose of ECHO-9 virus. On the basis of the results of these studies, compound 14 is a strong candidate for clinical evaluation as a systemic agent for the treatment of picornavirus infections.

  DOI：

  10.1021/jm00150a025

文献信息

• Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl)phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating
  作者：Guy D. Diana、Richard C. Oglesby、Vahan Akullian、Philip M. Carabateas、David Cutcliffe、John P. Mallamo、Michael J. Otto、Mark A. McKinlay、Edward G. Maliski、Stephen J. Michalec

  DOI：10.1021/jm00385a021

  日期：1987.2

  A series of substituted phenyl analogues of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles has been synthesized and evaluated in vitro against several human rhinovirus (HRV) serotypes. Substituents in the 2-position greatly enhanced activity when compared to the unsubstituted compound. Many of these compounds exhibited mean MICs (MIC) against five serotypes as low as 0.40 microM.

  已经合成了一系列5-[[[4-（4,5-二氢-2-恶唑基）苯氧基]烷基] -3-甲基异恶唑的取代苯基类似物，并在体外针对几种人鼻病毒（HRV）血清型进行了评估。与未取代的化合物相比，位于2位的取代基大大提高了活性。这些化合物中的许多都表现出针对低至0.40 microM的五种血清型的平均MIC（MIC）。平均MIC与MIC80（抑制80％所测试血清型的浓度）相关性很好（r = 0.83）。定量结构-活性关系研究表明，MIC与亲脂性（log P）以及诱导效应（sigma m）和体积因子（MW）密切相关。
• N-haloalkyl-4-(isoxazol-5-yl)alkoxy benzamides
  申请人：Sterling Drug, Inc.

  公开号：US05002960A1

  公开（公告）日：1991-03-26

  Compounds of the formulas: ##STR1## wherein Het is an oxazole or oxazine moiety; X is O, S or SO, n is an integer from 3 to 9, Y is an aliphatic bridge; and the various R groups represent hydrogen or various substituents as described herein, are useful as antiviral agents, especially against picornaviruses. N-(Chloroalkyl)amide intermediates for the compounds of Formula I are also active as antiviral agents. Related compounds outside the scope of the above formulas are also disclosed. Also disclosed are novel intermediates, N-halo-alkyl-4-(isoxazol-5-yl)alkoxybenzamides, also useful as antiviral agents.

  分子式为##STR1##的化合物，在其中Het是噁唑或噁唑烷基；X是O，S或SO，n是从3到9的整数，Y是脂肪桥；各种R基代表氢或如下所述的各种取代基，对于抗病毒剂，特别是对于小肠病毒具有用处。Formula I化合物的N-(氯代烷基)酰胺中间体也是作为抗病毒剂活性的。还披露了范围外的相关化合物。还披露了新的中间体，N-卤代烷基-4-(异噁唑-5-基)烷氧基苯甲酰胺，也可作为抗病毒剂使用。
• (Substituted) Phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof
  申请人：STERLING WINTHROP INC.

  公开号：EP0137242A2

  公开（公告）日：1985-04-17

  Compounds of the formulas and wherein R is lower-alkyl or substituted-lower-alkyl; R1, R2, R3 and R4 are each hydrogen, lower-alkyl or substituted lower-alkyl; R5 is hydrogen, lower-alkyl, halogen, nitro, lower-alkoxy, lower-alkylthio or trifluoromethyl; R6 is lower-alkyl; X is 0 or a single bond; and n is an integer from 3 to 9, are useful as antiviral agents, especially against picomaviruses.

  公式如下的化合物 和 其中 R 是低级烷基或取代的低级烷基；R1、R2、R3 和 R4 分别是氢、低级烷基或取代的低级烷基；R5 是氢、低级烷基、卤素、硝基、低级烷氧基、低级烷硫基或三氟甲基；R6 是低级烷基；X 是 0 或单键；n 是 3 至 9 的整数。
• Isoxazole and furan derivatives, their preparation and use as antiviral agents
  申请人：STERLING WINTHROP INC.

  公开号：EP0207454A2

  公开（公告）日：1987-01-07

  Compounds of the formula are wherein: R is hydrogen or alkyl of 1 to 3 carbon atoms optionally substituted by hydroxy, lower-alkoxy, lower-alkoxyalkoxy, lower-acyloxy, halo or N=Z', wherein N=Z' is amino, lower- slkanoylamino, lower-alkylamino, di-lower-alkylamino, 1-pyrrolidyl, 1-piperidiny) or 4-morpholinyl; X is 0 or CH2; Y is an alkylene bridge of 3-9 carbon atoms, optionally interrupted by an olefinic linkage; Z is N or R5C, where R5 is hydrogen or lower-alkanoyl, with the proviso that when Z is N, R is other than hydrogen; m is 0 or 1; R, and R2 are each halogen, methyl, nitro, lower- alkoxycarbonyl or trifluoromethyl; and R3 and R4 are each hydrogen or lower-alkyl of 1-3 carbon atoms; and pharmaceutically acceptable acid-addition salts thereof, as well as methods for preparation and use thereof. The compound exhibit valuable antiviral properties.

  式中的化合物 其中 R 是氢或任选被羟基、低级烷氧基、低级烷氧基烷氧基、低级乙氧基、卤素或 N=Z' 取代的 1 至 3 个碳原子的烷基，其中 N=Z' 是氨基、低级烷酰氨基、低级烷基氨基、二低级烷基氨基、1-吡咯烷基、1-哌啶基或 4-吗啉基； X 是 0 或 CH2； Y 是 3-9 个碳原子的亚烷基桥，可选择被烯烃链节打断； Z 是 N 或 R5C，其中 R5 是氢或低级烷酰基，但当 Z 是 N 时，R 不是氢； m 为 0 或 1； R 和 R2 分别是卤素、甲基、硝基、低级烷氧羰基或三氟甲基；以及 R3 和 R4 分别是氢或 1-3 个碳原子的低级烷基；以及 其药学上可接受的酸加成盐及其制备和使用方法。这些化合物具有宝贵的抗病毒特性。
• DIANA, G. D.;MCKINLAY, M. A.;OTTO, M. J.;AKULLIAN, V.;OGLESBY, C., J. MED. CHEM., 1985, 28, N 12, 1906-1910
  作者：DIANA, G. D.、MCKINLAY, M. A.、OTTO, M. J.、AKULLIAN, V.、OGLESBY, C.

  DOI：——

  日期：——